Purple Biotech Ltd (PPBT)
NASDAQ: PPBT · Real-Time Price · USD
3.940
+0.250 (6.78%)
At close: May 15, 2026, 4:00 PM EDT
3.930
-0.010 (-0.25%)
After-hours: May 15, 2026, 6:51 PM EDT
Purple Biotech Revenue
Revenue (ttm)
n/a
Revenue Growth
n/a
P/S Ratio
n/a
Revenue / Employee
n/a
Employees
10
Market Cap
6.37M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | - | - | - |
| Dec 31, 2024 | - | - | - |
| Dec 31, 2023 | - | - | - |
| Dec 31, 2022 | - | - | - |
| Dec 31, 2021 | - | - | - |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Moolec Science | 7.83M |
| Immuron | 4.99M |
| CollPlant Biotechnologies | 2.37M |
| XTL Biopharmaceuticals | 968.00K |
| Bio Green Med Solution | 747.00K |
| Silo Pharma | 72.10K |
| Alaunos Therapeutics | 5.00K |
PPBT News
- 18 days ago - Purple Biotech reports IM1240 demonstrates potent anti-tumor activity - TheFly
- 7 weeks ago - Purple Biotech announces collaboration with Converge Bio - TheFly
- 2 months ago - Purple Biotech regains compliance with Nasdaq - TheFly
- 2 months ago - Purple Biotech price target lowered to $30 from $34 at H.C. Wainwright - TheFly
- 2 months ago - Purple Biotech CEO Gil Efron to step down in August - TheFly
- 2 months ago - Purple Biotech reports Q4 EPS ($19.85) vs. ($2.00) last year - TheFly
- 2 months ago - Purple Biotech Announces CEO Transition - GlobeNewsWire
- 2 months ago - Purple Biotech trading halted, news pending - TheFly